<DOC>
	<DOCNO>NCT00049738</DOCNO>
	<brief_summary>The purpose study screen evaluate child psychotic disorder establish confirm diagnosis collect data condition . This study also recruit individual various treatment study . Childhood psychotic disorder debilitate condition child auditory visual hallucination disorganize thought . This study examine psychotic disorder child inpatient set . Participants study admit NIH Clinical Center 9 week one follow condition : current medication , medication , tapered medication . Participants undergo blood , urine , metabolic , intellectual functioning test . An electrocardiogram ( EKG ) electroencephalogram ( EEG ) perform . A magnetic resonance imaging ( MRI ) scan brain take infrared oculography use measure eye movement . Participants family member may also ask participate study genetics child psychotic illness . Children meeting criterion childhood onset schizophrenia may offer participation medication comparison protocol .</brief_summary>
	<brief_title>Screening Childhood-Onset Psychotic Disorders</brief_title>
	<detailed_description>Children adolescent age 5 18 , meet DSM IV criterion schizophrenia , schizoaffective disorder , psychotic disorder otherwise specify , currently study group . The purpose protocol allow systematic outpatient , subsequent inpatient screen evaluation establish accurate diagnosis research , obtain clinical neurobiological research measurement , evaluate patient 's response open treatment antipsychotic ( ) , allow longitudinal follow-up . Subjects first degree relative may enrol Protocol 89-M-0006 , Brain Imaging Childhood Onset Psychiatric Disorders , Endocrine Disorders Healthy Controls , Protocol 84-M-0050 , Biochemical , Physiological , Psychological Measures Normal Controls Relatives Psychiatric Patients . If additional research protocols available , screen protocol represent entry point . The evaluation process include one day outpatient psychiatric screen interview proband family . If think child likely meet criterion childhood onset psychosis , inpatient evaluation offer clarify diagnosis . This may involve : 1 ) Up 3 week inpatient observation child 's current medication regimen . 2 ) Tapering psychotropic medication ( 1-4 week , depend upon type dosage ) . 3 ) Observation 3 week drug free , order confirm diagnosis , 4 ) Once diagnosis confirm , two ten week treatment antipsychotic ( ) ; 5 ) Discharge care his/her community psychiatrist . Treatment guide consider subject 's best clinical interest . During inpatient stay , occasionally part outpatient screening , obtain neuropsychological testing , research blood draw include blood genetic testing proband , research brain MRI scan . A skin biopsy may obtain either inpatient stay follow visit . This protocol also include study 100 non-schizophrenic child age 6-13 psychotic symptom ( e.g . hallucination delusion ) extend study early neuro-developmental biomarkers factor either promote stop progression full schizophrenia ( resilience conversion factor ) . These child recruit local community , evaluate outpatient follow prospectively five year . Measures include diagnostic interview , clinical rating , cognitive testing , anatomic functional imaging , blood routine genetic testing .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>INPATIENT STUDY INCLUSION CRITERIA : Boys girl age 518 . Onset psychotic symptom 13th birthday presumptive diagnosis either schizophrenia , schizoaffective disorder , MDI syndrome , psychosis NOS . Prepsychotic IQ 70 . EXCLUSION CRITERIA : Major neurological medical condition ( e.g . temporal lobe epilepsy patient active treatment ) , psychiatric diagnosis main focus treatment ( e.g . serious eat disorder ) . OUTPATIENT STUDY : INCLUSION CRITERIA : 1 . Age 6 13 year old 2 . Presence psychotic symptom EXCLUSION CRITERIA : 1 . Major medical neurological illness 2 . IQ 70 , base either test data clinical assessment .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 15, 2016</verification_date>
	<keyword>Psychosis</keyword>
	<keyword>Childhood Onset Schizophrenia</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective</keyword>
	<keyword>Psychotic Disorder</keyword>
	<keyword>Multidimensionally Impaired Syndrome</keyword>
</DOC>